Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of autologous pCAR-19B CAR-T cells in pediatric and young adult CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia
CTR20220080Phase 2Active
- Sponsor
- Chongqing Precision Biotech
- Start
- Feb 2022
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of priscabtagene autoleucel, sponsored by Chongqing Precision Biotech. Started Feb 2022; status: active.
02
Drugs
priscabtagene autoleucel
Beyond the preview
Go deeper on CTR20220080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220080.